Rifaximin (Intestinal Antibiotic) Mega Study
Contents
Rifaximin (Intestinal Antibiotic)
Rifaximin (Intestinal Antibiotic)

Related

A
Count
A
Treatments
A
Effects

Tags

Rifaximin
intestinal Antibiotic

Treatment Effectiveness

User reported effectiveness ratings Rifaximin (Intestinal Antibiotic) for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Irritable Bowel Syndrome 25% 25% 25% 25% 0% 4

Below is the degree of change seen after Rifaximin (Intestinal Antibiotic) is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Rifaximin (Intestinal Antibiotic) Info

Property Value
Variable Name Rifaximin (intestinal Antibiotic)
Aggregation Method SUM
Analysis Performed At 2020-04-05
Duration of Action 21 days
Filling Value 0
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 0
Number of Measurements (including those generated by tagged, joined, or child variables) 0
Public true
Onset Delay 30 minutes
Unit Count
User Variables 0
Variable Category Treatments
Variable ID 95124